A Pilot Study of Three-Week, Randomised, Open Comparison in Schizophrenic In-Patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose
Phase of Trial: Phase III
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Quetiapine; Risperidone
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 04 Mar 2009 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 23 Jan 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 07 May 2008 New trial record.